Suppr超能文献

具有外环氨基部分(增加距离 1)的螺环 σ(1)受体配体的设计、合成和药理学评价。

Design, synthesis and pharmacological evaluation of spirocyclic σ(1) receptor ligands with exocyclic amino moiety (increased distance 1).

机构信息

Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Germany.

出版信息

Bioorg Med Chem. 2011 May 15;19(10):3141-51. doi: 10.1016/j.bmc.2011.04.002. Epub 2011 Apr 6.

Abstract

Various pharmacophore models for potent σ(1) ligands specify a basic amino group flanked by two different hydrophobic regions in defined distances to the basic amine (distance 1 and distance 2, respectively). According to these models distance 1 of the potent spirocyclic σ(1) ligand 1 is too short. In order to find a new class of more potent σ(1) ligands and to verify the distance hypothesis of the pharmacophore models spirocyclic compounds 2 with an exocyclic amino group were designed and synthesized. The secondary amines 8 and 9 with N-benzyl residues are >100-fold less potent than the spirocyclic piperidine 1. However, the tertiary methylamines trans-11 and cis-11 represent potent σ(1) ligands with K(i)-values of 43 and 24 nM, respectively. Whereas one large benzyl moiety is required for high σ(1) receptor binding, a second large N-substituent is not tolerated by the σ(1) receptor protein. As a rule, cis-configured diastereomers with a longer distance 1 (predominantly 7.16-7.23 Å) show higher σ(1) affinities than their trans-configured counterparts (distance 1 is predominantly 5.88-6.26 Å).

摘要

各种强效 σ(1)配体的药效团模型规定,碱性氨基基团两侧分别有两个不同的疏水区,与碱性胺的距离分别为距离 1 和距离 2。根据这些模型,强效螺环 σ(1)配体 1 的距离 1 太短。为了找到一类新的更强效的 σ(1)配体,并验证药效团模型的距离假设,设计并合成了具有外环氨基的螺环化合物 2。具有 N-苄基残基的仲胺 8 和 9 的效力比螺环哌啶 1 低 100 倍以上。然而,反式-11 和顺式-11 的叔甲基胺是强效的 σ(1)配体,其 K(i)值分别为 43 和 24 nM。尽管一个大的苄基部分对于高 σ(1)受体结合是必需的,但第二个大的 N-取代基不能被 σ(1)受体蛋白耐受。通常,具有较长距离 1(主要为 7.16-7.23 Å)的顺式构型非对映异构体比其反式构型对应物(距离 1 主要为 5.88-6.26 Å)具有更高的 σ(1)亲和力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验